Centinel Spine marked the first implantation of angled endplates with the prodisc® L Lumbar Total Disc Replacement System in the U.S. The endplates are designed to shift the lordotic angle of the implant to the inferior endplate, offering options to address the varied lumbar anatomy and pathology of patients.
Six angled endplate options for prodisc L have been added as part of this release, including inferior endplates with lordotic angles of 3° and 8° and a superior endplate with a lordotic angle of 3°. Limited commercial U.S. release will continue through 2020, with full market release to follow in early 2021.
During 2020, the company gained FDA approval of two-level indications for prodisc L; launched a patient reimbursement support program designed to further expand patient access to prodisc L; and advanced patient enrollment on a two-level clinical trial comparing two new prodisc C device configurations. Centinel Spine is the only company with FDA-approved cervical and lumbar total disc replacement devices, and prodisc L is the only total disc replacement system in the U.S. approved for two-level use in the lumbar spine.
Centinel Spine’s CEO, Steve Murray, stated, “As a company, we care deeply about advancing patient care and are proud to bring innovative technologies to surgeons and patients. Centinel Spine will continue to innovate, bringing to market clinically-proven, high-quality technologies meeting the challenges faced by our surgeon partners.”
Centinel Spine marked the first implantation of angled endplates with the prodisc® L Lumbar Total Disc Replacement System in the U.S. The endplates are designed to shift the lordotic angle of the implant to the inferior endplate, offering options to address the varied lumbar anatomy and pathology of patients.
Six angled endplate options...
Centinel Spine marked the first implantation of angled endplates with the prodisc® L Lumbar Total Disc Replacement System in the U.S. The endplates are designed to shift the lordotic angle of the implant to the inferior endplate, offering options to address the varied lumbar anatomy and pathology of patients.
Six angled endplate options for prodisc L have been added as part of this release, including inferior endplates with lordotic angles of 3° and 8° and a superior endplate with a lordotic angle of 3°. Limited commercial U.S. release will continue through 2020, with full market release to follow in early 2021.
During 2020, the company gained FDA approval of two-level indications for prodisc L; launched a patient reimbursement support program designed to further expand patient access to prodisc L; and advanced patient enrollment on a two-level clinical trial comparing two new prodisc C device configurations. Centinel Spine is the only company with FDA-approved cervical and lumbar total disc replacement devices, and prodisc L is the only total disc replacement system in the U.S. approved for two-level use in the lumbar spine.
Centinel Spine’s CEO, Steve Murray, stated, “As a company, we care deeply about advancing patient care and are proud to bring innovative technologies to surgeons and patients. Centinel Spine will continue to innovate, bringing to market clinically-proven, high-quality technologies meeting the challenges faced by our surgeon partners.”
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
